Interaction of fatty acid with myoglobin  by Sriram, Renuka et al.
FEBS Letters 582 (2008) 3643–3649Interaction of fatty acid with myoglobin
Renuka Sriram, Ulrike Kreutzer, Lifan Shih, Thomas Jue*
Department of Biochemistry and Molecular Medicine, University of California Davis, Davis, CA 95616-8635, USA
Received 15 August 2008; revised 17 September 2008; accepted 25 September 2008
Available online 7 October 2008
Edited by Miguel De la RosaAbstract Upon titration with palmitate, the 1H NMR spectra
of metmyoglobin cyanide (MbCN) reveal a selective perturba-
tion of the 8 heme methyl, consistent with a speciﬁc interaction
of myoglobin (Mb) with fatty acid. Other detectable hyperﬁne
shifted resonances of the heme group remain unchanged. Mb also
enhances fatty acid solubility, as reﬂected in a more intense
methylene peak of palmitate in Mb solution than in Tris buﬀer.
Ligand binding analysis indicates an apparent palmitate
dissociation constant (Kd) of 43 lM. These results suggest that
Mb can bind fatty acid and may have a role in facilitating fatty
acid transport in the cell.
 2008 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The physiology canon asserts that Mb serves as an O2 store
or facilitates O2 transport. Textbooks have embraced the con-
cept; even though in vivo experiments have presented conﬂict-
ing evidence [1]. Certainly, Mb can supply O2 during a
transient decrease in the O2 supply, such as during a marine
mammal dive or during the initiation of muscle contraction
[2–5]. Mb concentration also appears to correlate with the aer-
obic capacity in diﬀerent species. Yet in mammalian heart, the
O2 store of Mb actually prolongs respiration in a rat heart for
only a few seconds during anoxia. CO inactivation of Mb func-
tion elicits no compensating response in bioenergetics or con-
tractile function. Moreover, Mb appears to diﬀuse too slowly
in many physiological states to compete eﬀectively with free
O2 diﬀusion to transport intracellular O2 [6–9]. Even without
any Mb, a mouse model exhibits no detectable impairment
in respiration, contractile function, bioenergetics, and metabo-
lism [10,11]. These observations have raised questions about
Mb function and have spawned complex explanations about
multiple compensating mechanisms as well as a controversial
hypothesis about Mb scavenging of NO [12,13]. The in vivo
experimental data do not deﬁnitively conﬁrm that Mb has
any overarching function as an O2 store or as O2 transporter,
especially in the myocardium.
Alternatively, the experimental evidence may simply indicate
that Mb has another signiﬁcant function in the cell. Indeed,
Mb knockout mice do exhibit a slight decrease in myocardial*Corresponding author. Fax: +1 530 752 3516.
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doi:10.1016/j.febslet.2008.09.047fatty acid metabolism relative to the wild type mouse [14]. In-
stead of ascribing the metabolic change to a limitation in intra-
cellular O2 diﬀusion, which in vivo experimental measurements
have not fully supported, we have hypothesized that the ab-
sence of Mb actually diminishes the cells capacity to facilitate
fatty acid diﬀusion. That viewpoint helps clarify the emerging
model of intracellular fatty acid transport, in which the high
aﬃnity fatty acid binding protein (FABP) plays a prominent
role [15]. To test such an idea about Mb, however, requires
experimental evidence that Mb can interact with fatty acid
and enhances fatty acid solubility.
Indeed, 1H NMR measurements of palmitate (PA) titration
in MbCN solution reveal a selective change in the 8 heme
methyl signal, consistent with a speciﬁc interaction in a local-
ized region of Mb. Moreover, palmitate appears more soluble
in Mb solution than in buﬀer. These observations suggest then
that Mb may indeed serve as an intracellular fatty acid trans-
porter.2. Materials and methods
2.1. Protein preparation
Myoglobin solution was prepared from lyophilized horse heart pro-
tein (Sigma Chemical Inc., St. Louis, MO). All samples were prepared
in 30 mM Tris buﬀer with 1 mM EDTA at pH 7.4. The pH was mea-
sured at 35 C using a calomel electrode (Orion 7110BN Micro Calo-
mel pH, Thermo Electron Corporation). For MbCN, ﬁve times excess
KCN was added to the metmyoglobin in Tris, and the pH was adjusted
to 7.4.
2.2. Fatty acid-Mb preparation
Sodium palmitate (Sigma Chemical Inc.) was dissolved in 30 mM
Tris buﬀer with 1 mM EDTA at pH 8.5 at 65 C. Stock solutions of
10 mM and 100 mM were prepared for addition to myoglobin protein
solutions and kept in a heating block (Thermolyne 17600 Dri-Bath) at
65 C. 10–100 mM palmitate (PA) was added to myoglobin to yield a
ﬁnal solution with diﬀerent PA:Mb ratios. For the NMR experiments,
two separate heating blocks maintained the PA solution at 65 C and
the Mb solution at 35 C, respectively. Aliquots of PA in Tris buﬀer at
65 C were added to 600 ll of myoglobin solution maintained at 35 C.
Immediately after the PA addition, the sample was transferred to a
5 mm NMR tube. The NMR probe was also maintained at 35 C.
The time between PA addition and the start of the NMR measurement
was approximately 10 min.2.3. NMR
An Avance 500-MHz Bruker spectrometer measured the 1H signals
with a 5 mm probe. The 1H 90 pulse, calibrated against the H2O sig-
nal from a 0.15 M NaCl solution was 9 ls. A Watergate pulse sequence
was used to suppress the solvent peak. Sodium-3-(trimethylsilyl) propi-
onate 2,2,3,3 d4 (TSP) served as the internal chemical shift and concen-
tration reference. All samples contained 5% D2O to enable the lock
during signal acquisition. All measurements were carried out at
35 C. A typical spectrum required 1024 scans and used the followingation of European Biochemical Societies.
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and 107-ms recycle time. Zero-ﬁlling the free induction decay (FID)
and apodizing with an exponential window function improved the
spectra. A spline ﬁt then smoothed the baseline.
2.4. Fatty acid binding aﬃnity
The curve ﬁt used equations to express speciﬁc and non-speciﬁc
binding at two sites [16]. For the ﬁrst site, the equation
½PAbound ¼
Bmax½PAfree
Kdþ½PAfree determined a one site speciﬁc binding of palmitate
to Mb based on the signal intensity loss of the 8 heme methyl. For 2
site binding, corresponding to speciﬁc and non-speciﬁc binding, the
curve ﬁt used the equationFig. 1. 1H NMR spectra of 0.8 mMMbCN with and without palmitate in Tr
Spectrum of 0.8 mM MbCN with 0.8 mM TSP and with PA at a PA:Mb rat
0.8 mMMbCN with 0.8 mM TSP and with and without palmitate at a PA:Mb
TSP and with and without palmitate at a PA:Mb ratio of 0.9:1. The peaks
groups. Palmitate induces a selective signal intensity loss in the 8 heme peak½PAbound ¼
Bmax½PAfree
Kd þ ½PAfree
þ B
0
max½PAfree
K 0d þ ½PAfree
Assuming K0d [PA]free
½PAbound ¼
Bmax½PAfree
Kd þ ½PAfree
þ N s½PAfree
where N s ¼ BmaxKd . [PA] is palmitate concentration; Kd is dissociation
constant; and Bmax, B
0
max = maximum capacity for speciﬁc and non-
speciﬁc palmitate binding, respectively.
The analysis assumes that the speciﬁc binding of fatty acid to Mb
reduces the 8 heme methyl signal and the speciﬁc and non-speciﬁcis buﬀer at pH 7.4 35 C: (A) Control spectrum of 0.8 mMMbCN. (B)
io of 0.4:1. (C) Diﬀerence spectrum (A–B). (D) Diﬀerence spectrum of
ratio of 0.6:1. (E) Diﬀerence spectrum of 0.8 mMMbCN with 0.8 mM
at 26.4, 17.9, and 13.2 ppm correspond to the 5, 1 and 8 heme methyl
intensity.
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lene peak. Subtracting the bound palmitate concentration derived from
the observed methylene lipid signal from the total palmitate added to
the solution yields an estimate of the free palmitate concentration.
2.5. Statistical analysis
Statistical analysis used the Sigma Plot/Sigma Stat program (Systat
Software, Inc., Point Richmond, CA) and expressed the data as mean
value ± standard error (S.E.). Non-linear regression analysis of the
average data points determined the dissociation constant using Marqu-
ardt–Levenberg algorithm [17]. Statistical signiﬁcance was determined
by two-tailed Students T-test, P < 0.05.Fig. 2. 1H NMR spectra of the upﬁeld region of 0.8 mMMbCN with and wit
0.8 mM without PA or TSP. (B) 0.8 mM MbCN with 0.8 mM TSP and with
spectrum of 0.8 mMMbCN with and without TSP and PA at a PA:Mb ratio o
and PA at a PA:Mb ratio of 4:1. The peak at 1.17 ppm in the diﬀerence sp
originates from TSP. The methylene PA peak increases with PA:Mb ratio.3. Results and discussion
3.1. Spectral change
Fig. 1A displays the downﬁeld region of the MbCN spectra.
In the literature, many studies have used MbCN as a surrogate
model for the physiological MbO2, because it shares similar
structural features but exhibits observable hyperﬁne shifted
resonances of the heme groups away from the crowded dia-
magnetic region [18]. Speciﬁcally the prominent peaks at
26.4, 17.9, and 13.2 ppm correspond to the 5, 1, 8 methylhout PA in Tris buﬀer at pH 7.4 and at 35 C: (A) Control spectrum of
PA at PA:Mb of 1:1. (C) Diﬀerence spectrum (BA). (D) Diﬀerence
f 2:1. (E) Diﬀerence spectrum of 0.8 mMMbCN with and without TSP
ectra arises from the methylene peak of PA, while the peak at 0 ppm
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the 8 heme methyl signal intensity decreases. Fig. 1B displays
the MbCN spectrum with the PA:Mb ratio of 0.4:1. The diﬀer-
ence spectrum (Fig. 1A and B), reveals that palmitate induces
only an 8 heme methyl signal intensity loss (Fig. 1C). The dif-
ference spectra with PA:Mb ratios of 0.6:1 and 0.9:1 show a
only a slight change in the 8 heme methyl signal intensity
(Fig. 1D and E).
In the upﬁeld region, PA titration also produces distinct
spectral changes. Fig. 2 shows the MbCN spectra with diﬀer-
ent ratios of PA:Mb. The control spectrum of MbCN ap-
pears in Fig. 2A. Fig. 2B shows 0.8 mM MbCN with
0.8 mM PA and 0.8 mM sodium-3-(trimethylsilyl) propio-
nate-2,2,3,3-d4 (TSP). TSP serves as the chemical shift
(0 ppm) and concentration reference. The diﬀerence spectra
(Fig. 2B and A) show the palmitate signal with the prominent
methylene (–CH2–)12 peak at 1.17 ppm (Fig. 2C). Even
though above a PA:Mb ratio of 0.6:1, the 8 heme methyl
peak decreases insigniﬁcantly with additional PA, the palmi-
tate methylene peak, in contrast, continues to grow. Between
PA:Mb ratios of 2:1 and 4:1, the palmitate signal increases
noticeably (Fig. 2D and E).Fig. 3. 1H NMR spectra of PA in Tris, MbCN, and lysozyme at pH 7.4 an
spectrum of MbCN with and without 0.4 mM PA at PA:Mb ratio of 2:1. (
PA:lysozyme ratio of 2:1. In Tris, the spectrum shows less than 1% of the tot
31% of the PA becomes NMR detectable. The methylene PA signal shifts toFig. 3 shows the diﬀerence spectra of buﬀer, MbCN, and
lysozyme with and without 0.4 mM palmitate in 30 mM Tris
and 1 mM EDTA buﬀer at pH 7.4 at 35 C. In the spectrum
of 0.4 mM PA in Tris buﬀer, the PA methylene peak resonates
at 1.28 ppm. Fig. 3B shows the diﬀerence spectrum of 0.2 mM
of MbCN with and without 0.4 mM PA. A more intense pal-
mitate CH2 signal appears at 1.17 ppm, 0.1 ppm upﬁeld of
the corresponding position in buﬀer. Fig. 3C shows the diﬀer-
ence spectrum of 0.2 mM lysozyme with and without 0.4 mM
palmitate. No detectable signal of palmitate appears. Cali-
brated against the TSP signal, the spectra indicate that
NMR detects only 0.8% of the added PA in Tris buﬀer, 31%
in MbCN, and 0% in lysozyme. In MbCN, the detected PA
signal indicates that palmitate has about 40 times greater sol-
ubility in Mb solution than in Tris buﬀer. Table 1 compares
the palmitate solubility in diﬀerent solutions.
3.2. Speciﬁc vs. non-speciﬁc interaction
Because the chemical shifts of the PA methylene signal in
buﬀer and Mb diﬀer by 0.1 ppm, the analysis has assumed
the observed PA signal arises from a fatty acid interaction with
Mb. Such assumption agrees with literature report that fattyd at 35 C: (A) Spectrum of 0.4 mM PA in Tris buﬀer. (B) Diﬀerence
C) Diﬀerence spectrum of lysozyme with and without 0.4 mM. PA at
al PA signal. The methylene PA signal appears at 1.28 ppm. In MbCN,
1.17 ppm in Mb solution. In lysozyme, no PA signal appears.
Table 1
Solubility of palmitate
Solution PA solubility (M) PA solubility (g of PA/100 g of solvent) Reference
Tris buﬀer pH 7.4 35 C 3.16 · 106 87.9 · 106 This work
0.2 mM MbCN in Tris, pH 7.4 35 C 0.13 · 103 36.2 · 104 This work
0.2 mM Lysozyme in Tris, pH 7.4 35 C 0 0 This work
Water 30 C 32 · 106 83 · 105 [31]
99.4% of Ethanol at 30 C 0.93 23.9 [31]
Acetone at 30 C 0.61 15.6 [31]
Benzene at 30 C 1.35 34.8 [31]
Glacial acetic acid at 30 C 0.31 8.11 [31]
66 mM Phosphate buﬀer, pH 7.4 at 37 C <1010 <27.8 · 1010 [32]
Fig. 4. Graph of bound and observed PA vs. free PA based on the 8
heme methyl and the palmitate methylene signals based on 3
independent sets of experiments (n = 3): (A) The bound PA concen-
tration derives from the signal of the 8 heme methyl during PA
titration and provides a basis for the curve ﬁt, which assumes a single
site binding. (B) The bound PA concentration derives from the PA
methylene signal intensity in the diﬀerence spectra during PA titration
and provides a basis for the curve ﬁt, which assumes both a speciﬁc
and a non-speciﬁc binding site.
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distinct from the corresponding 13C signal in buﬀer [20].
A plot of the free PA concentration vs. the bound PA in Mb
solution shows a non-linear relationship, with a faster rising
component at low PA concentration (Fig. 4). Analyzing the
curve with a speciﬁc and a non-speciﬁc site yields an apparent
Kd of 0.035 ± 0.008 mM and the coeﬃcient, Ns = 0.33.
Fig. 4 also plots the free and bound PA based on the analysis
of the 8 heme methyl Mb signal intensity in three independent
sets of experiments (n = 3). The analysis envisions that the 8
heme methyl signal intensity loss arises from a local PA bind-
ing to Mb. With PA:Mb ratio above 2:1, the signal intensity
loss plateaus around 50%. A curve ﬁt to an equation for one
speciﬁc binding site yields an apparent dissociation constant
(Kd) of 0.043 ± 0.013 mM.
3.3. Local perturbation
The selective intensity loss of the 8 heme methyl signal sup-
ports the hypothesis that PA interacts in a local structural re-
gion of Mb. That interaction presumably reduces the heme
methyl mobility, which alters the relaxation rate and broadens
the peak beyond solution state NMR detection. Such a molec-
ular picture agrees with Mb solution and crystallographic stud-
ies, which depict the heme 7 propionate adjacent to the 8
methyl as a ﬂexible group with the carboxyl group exposed
to the solvent. The adjacent 6 propionate next to the 5 heme
methyl also faces the solvent. However, the hydrogen bonding
to amino acid residues, such as the FG3 histidine, reduces the
accessibility to the 5 heme methyl region and introduces a
molecular gate in a proposed O2 pathway to the heme [21]. In-
deed, the 5 heme methyl signal shows no signal intensity
change upon the addition of PA. The 1 methyl group residing
inside the hydrophobic heme pocket has no exposure to sol-
vent. It and other observable hyperﬁne peaks show no PA in-
duced change.
Unfortunately, the 1D NMR analysis cannot distinguish a
partial loss of signal intensity of the 1 proton heme propionate
signals in MbCN spectra, which resonate in the overcrowded
spectral region from 0.07 to 1.56 ppm at 35 C [22]. Addi-
tional NMR experiments must map in detail the speciﬁc Mb
structural interaction with fatty acid.
3.4. Palmitate binding to Mb
The experimental data suggest that Mb can bind to PA and
broaden the monolithic view that only fatty acid binding pro-
tein (FABP) traﬃcs fatty acid in the cell. Rat heart has about
50 lM of FABP with a Kd of 14 nM but has 260 lM of Mb
[23–25]. The present study shows an apparent Kd of 35–
43 lM. The apparent Mb Kd, however, derives from theassumption that all PA in solution can interact with Mb.
Clearly with 0.8 mM MbCN with a PA:Mb ratio of 1:1, the
detection of only 31% of the total signal and no detection of
any signal with a chemical shift observed in buﬀer, indicates
only a fractional amount PA may actually participate in bind-
ing to Mb, and the diﬀerent PA states, involving most likely,
the solution NMR undetectable lamellar state, probably exist
in dynamic equilibrium.
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in Mb suggests a non-speciﬁc interaction that exceeds the stoi-
chiometric amount required to saturate the Mb binding site.
Despite the lower binding aﬃnity, the higher concentration
of Mb and the enhanced fatty acid solubility may still allow
Mb to compete eﬀectively with FABP as a carrier of intracel-
lular fatty acid.
3.5. Mb and fatty acid transport
Imputing a fatty acid transport role for Mb agrees with pre-
vious literature studies and casts a diﬀerent perspective on the
biochemical mechanism maintaining metabolic homeostasis in
the cell. Early experiments found 14C labeled oleic acid binding
to a rat heart cytosolic fraction of 16 kDa and implicated a Mb
role in fatty acid binding [26]. However, the study did not dis-
tinguish the potential contribution from the 15 kDa FABP.
Subsequent experiments, however, showed Mb has approxi-
mately 40 times lower binding capacity than albumin on a
per mole basis, which based on the presented evidence would
extrapolate to a Mb Kd of 12.2–48 lM, in agreement with
NMR determined apparent Kd value [27].
It might appear that low binding aﬃnity of Mb for fatty acid
would militate against any role in transporting fatty acid, cur-
rently ascribed almost exclusively to FABP with its high PA
binding aﬃnity. Dissociating the fatty acid from FABP, how-
ever, usually invokes a complex release mechanism [28]. With
Mb, the lower aﬃnity, higher protein concentration, and in-
creased fatty acid solubility, may well skirt the need for such
complex mechanism. Moreover, FABP mobility in the cell re-
mains uncertain, whereas Mb diﬀusion in the cell can compete
with free O2 diﬀusion under certain physiological conditions
[8,9].4. Conclusion
The selective change in the 1H NMR signal of the 8 heme
methyl of MbCN during palmitate titration and the increased
palmitate solubility in the presence of Mb points to a role for
Mb in transporting fatty acid and sets the basis for future
experiments, which must conﬁrm its role in regulating fatty
acid metabolism. Such a role would broaden the cells ability
to meet a range of metabolic demands and suggests an alterna-
tive explanation of how exercise, which can increase Mb con-
centration in skeletal muscle, might regulate the system glucose
and lipid metabolism [29,30]. The present study then has estab-
lished a basis to explore the potential role of Mb in fatty acid
binding and transport.
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